header image

News

Octapharma sponsors symposium ‘Haemophilia A: Individualised solutions to global challenges’ at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Toronto, Canada

13.07.2015

LACHEN, Switzerland, July 13th, 2015 – Octapharma sponsored the symposium ‘Haemophilia A: Individualised solutions to global challenges’ at the ISTH Congress in Toronto, Canada, on June 23rd, 2015. The symposium provided an...

Octapharma sponsors symposium ‘Addressing complex issues in VWD & haemophilia care’ at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Toronto, Canada

13.07.2015

LACHEN, Switzerland, July 13th, 2015 – Octapharma sponsored the symposium ‘Addressing complex issues in VWD & haemophilia care’ at the ISTH Congress in Toronto, Canada, on June 24th, 2015. The symposium, chaired by Professor...

Octapharma supports 2nd Spring Forum Haemophilia ‘New Avenues in Human Recombinant Factor VIII (rFVIII) Replacement: Perspectives and Challenges for the Years Ahead’ in Berlin, Germany

21.04.2015

Lachen, Switzerland, April 21st, 2015 – Octapharma supported the 2nd Spring Forum Haemophilia ‘New Avenues in Human rFVIII Replacement: Perspectives and Challenges for the Years Ahead’, held in Berlin, Germany, on April 17th and...

World Haemophilia Day 2015

17.04.2015

Lachen, Switzerland, April 17th, 2015: today on World Haemophilia Day Octapharma is hosting a special two day scientific event in Berlin, Germany entitled “New Avenues in Human rFVIII Replacement: Perspectives and Challenges for...

Octapharma Group release 2014 Annual Report

03.03.2015

Lachen, Switzerland, March 3rd, 2015: the Octapharma Group releases its 2014 Annual Report which reports revenue of 1.280 billion Euro in 2014, representing an increase of 126 million Euro or 11% compared to the 2013 figure....